Novartis AG is 172.4x more valuable than Biohaven Ltd. by market capitalization ($283.13 B vs $1.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHVN | NVS |
|---|---|---|
| Market cap | $1.64 B | $283.13 B |
| US-listed rank | #2254 | #47 |
| Net income (latest FY) | -$738.82M | - |
| SEC filings | 265 | 947 |
Novartis AG is 172.4x more valuable than Biohaven Ltd. by market capitalization ($283.13 B vs $1.64 B).
Full pages: Biohaven Ltd. and Novartis AG, or browse the full rankings.